Acetazolamide Completed Phase 4 Trials for Alkalosis / Respiratory Insufficiency Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00222534Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis